Literature DB >> 24589260

Hemoglobin s polymerization and red cell membrane changes.

Frans A Kuypers1.   

Abstract

Different pathways lead from the simple point mutation in hemoglobin to the membrane changes that characterize the altered interaction of the sickle red blood cell with its environment, including endothelial cells, white blood cells, and platelets. Polymerization and oxidation-induced damage to both lipid and protein components of the red cell membrane, as well as the generation of bioreactive membrane material (microparticles), has a profound effect on all tissues and organs, and defines the vasculopathy of the patient with sickle cell disease.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Membrane lipids; Microparticles; Oxidative damage; Polymerization

Mesh:

Substances:

Year:  2014        PMID: 24589260     DOI: 10.1016/j.hoc.2013.12.002

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  10 in total

Review 1.  Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease.

Authors:  Marilyn J Telen
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

2.  Congolese children with sickle cell trait may exhibit glomerular hyperfiltration: A case control study.

Authors:  Michel Ntetani Aloni; René Makwala Ngiyulu; Célestin Ndosimao Nsibu; Pépé Mfutu Ekulu; Jean Robert Makulo; Jean-Lambert Gini-Ehungu; Nazaire Mangani Nseka; François Bompeka Lepira
Journal:  J Clin Lab Anal       Date:  2017-01-19       Impact factor: 2.352

3.  Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease.

Authors:  Jon A Detterich; Roberta M Kato; Miklos Rabai; Herbert J Meiselman; Thomas D Coates; John C Wood
Journal:  Blood       Date:  2015-06-02       Impact factor: 22.113

4.  Red blood cell mechanical sensitivity improves in patients with sickle cell disease undergoing chronic transfusion after prolonged, subhemolytic shear exposure.

Authors:  Michael J Simmonds; Silvie Suriany; Derek Ponce; Jon A Detterich
Journal:  Transfusion       Date:  2018-10-16       Impact factor: 3.157

Review 5.  Oxidative pathways in the sickle cell and beyond.

Authors:  Abdu I Alayash
Journal:  Blood Cells Mol Dis       Date:  2017-05-20       Impact factor: 3.039

Review 6.  Hyperinflammation, apoptosis, and organ damage.

Authors:  Frans A Kuypers
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-27

Review 7.  Redox Balance in β-Thalassemia and Sickle Cell Disease: A Love and Hate Relationship.

Authors:  Rayan Bou-Fakhredin; Lucia De Franceschi; Irene Motta; Assaad A Eid; Ali T Taher; Maria Domenica Cappellini
Journal:  Antioxidants (Basel)       Date:  2022-05-13

Review 8.  Inflammatory targets of therapy in sickle cell disease.

Authors:  Amma Owusu-Ansah; Chibueze A Ihunnah; Aisha L Walker; Solomon F Ofori-Acquah
Journal:  Transl Res       Date:  2015-07-11       Impact factor: 7.012

Review 9.  In utero Therapy for the Treatment of Sickle Cell Disease: Taking Advantage of the Fetal Immune System.

Authors:  Alba Saenz de Villaverde Cortabarria; Laura Makhoul; John Strouboulis; Giovanna Lombardi; Eugene Oteng-Ntim; Panicos Shangaris
Journal:  Front Cell Dev Biol       Date:  2021-01-22

10.  The Platelet Count and its Implications in Sickle Cell Disease Patients Admitted for Intensive Care.

Authors:  Durjoy K Shome; Ahmed Jaradat; Ahmed I Mahozi; Ali S Sinan; Ali Ebrahim; Mohammed Alrahim; Mohammad S Ebraheem; Eman J Mansoor; Kameela S Majed; Sheikh A Azeez Pasha
Journal:  Indian J Crit Care Med       Date:  2018-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.